Question 1

Does Woodline Partners own ALXN stock?

Accepted Answer

No. Woodline Partners exited its ALXN (Alexion Pharmaceuticals) position in Q4 2020. Its Q3 2020 13F listed 466,572 shares worth $53.4M.

Question 2

How many shares of ALXN does Woodline Partners own?

Accepted Answer

None since Q4 2020, when Woodline Partners exited the position. Its Q3 2020 13F listed 466,572 shares worth $53.4M.

Question 3

What is Woodline Partners' ALXN position worth?

Accepted Answer

Woodline Partners' ALXN position was worth $53.4M in its Q3 2020 13F, before the exit in Q4 2020.

Question 4

Is Woodline Partners buying or selling ALXN?

Accepted Answer

In Q4 2020, Woodline Partners exited its entire ALXN position.

Question 5

When did Woodline Partners first buy ALXN?

Accepted Answer

Woodline Partners already held ALXN in its Q4 2019 13F, the earliest on record, and listed it in 4 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2020-Q4 Latest	Exited	0	-100.0%	$0	0.0%	—	0
2020-Q3	Increased	466,572	+104.4%	$53.4M	1.7%	—	75
2020-Q2	Increased	228,253	+3.7%	$25.6M	1.0%	—	47
2020-Q1	Increased	220,149	+92.8%	$19.8M	1.4%	—	71
2019-Q4	First report	114,170	-	$12.3M	0.5%	—	0

ALXN5 quarters

ALXN
5 quarters